Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Collect Additional Safety and Effectiveness Data for the Biosensors BioFreedom™ BA9 Drug Coated Coronary Stent in Patients With Native, de Novo Coronary Artery Disease

NCT02131142 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.

NCT NCT02131142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02131142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Collect Additional Safety and Effectiveness Data for the Biosensors BioFreedom™ BA9 Drug Coated Coronary Stent in Patients With Native, de Novo Coronary Artery Disease
Lead sponsor
Biosensors Europe SA
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 31, 2014
Completion date
July 31, 2019
Enrollment
72 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic heart disease, silent ischemia, stable angina, unstable angina